PIMCO Dynamic Income Strategy Fund
(NYSE:PDX)
$
23.29
0.19 (0.82%)
Market Cap: 1.04 Bil
Enterprise Value: 1.19 Bil
PE Ratio: 4.19
PB Ratio: 1.03
GF Score: 41/100 - Q3 2023 Pediatrix Medical Group Inc Earnings Call TranscriptNov 02, 2023$19.6 (+1.24%)Earnings
- Q2 2023 Pediatrix Medical Group Inc Earnings Call TranscriptAug 03, 2023$16.53 (+0.24%)Earnings
- Pediatrix Medical Group Inc at Bank of America Global Healthcare Conference TranscriptMay 10, 2023
- Q1 2023 Pediatrix Medical Group Inc Earnings Call TranscriptMay 02, 2023$14.42 (-1.90%)Earnings
- Q4 2022 Pediatrix Medical Group Inc Earnings Call TranscriptFeb 17, 2023$15.4 (-1.66%)Earnings
- Q3 2022 Pediatrix Medical Group Inc Earnings Call TranscriptNov 03, 2022$15.54 (+0.91%)Earnings
- Q2 2022 Pediatrix Medical Group Inc Earnings Call TranscriptAug 04, 2022$14.4 (-2.04%)Earnings
- Q1 2022 MEDNAX Inc Earnings Call TranscriptApr 28, 2022$14.61 (+2.31%)Earnings
- Q4 2021 MEDNAX Inc Earnings Call TranscriptFeb 17, 2022$13.81 (-0.50%)Earnings
- MEDNAX Inc at Bank of America Leveraged Finance Conference (Virtual) TranscriptNov 30, 2021
- MEDNAX Inc at Credit Suisse Healthcare Conference (Virtual) TranscriptNov 10, 2021
- Q3 2021 MEDNAX Inc Earnings Call TranscriptOct 28, 2021$13.17 (-0.30%)Earnings
- MEDNAX Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 15, 2021
- Q2 2021 MEDNAX Inc Earnings Call TranscriptAug 06, 2021$11.47 (+0.26%)Earnings
- MEDNAX Inc Annual Shareholders Meeting TranscriptMay 12, 2021
- Q1 2021 MEDNAX Inc Earnings Call TranscriptMay 07, 2021$11.2 (+0.54%)Earnings
- Q4 2020 MEDNAX Inc Earnings Call TranscriptFeb 18, 2021$9.86Earnings
- Q3 2020 MEDNAX Inc Earnings Call TranscriptNov 06, 2020$6.31 (-1.71%)Earnings
- MEDNAX Inc Annual Shareholders Meeting TranscriptSep 09, 2020
- Q2 2020 MEDNAX Inc Earnings Call TranscriptJul 30, 2020$6.93 (-2.26%)Earnings
- MEDNAX Inc Business Update Conference Call/Webcast TranscriptJun 05, 2020
- Q1 2020 MEDNAX Inc Earnings Call TranscriptMay 07, 2020$7.4 (+0.68%)Earnings
- Q4 2019 MEDNAX Inc Earnings Call TranscriptFeb 20, 2020$15.89Earnings
- MEDNAX Inc at Bank of America Merrill Lynch Leveraged Finance Conference TranscriptDec 03, 2019
- MEDNAX Inc at Credit Suisse Healthcare Conference - Scottsdale TranscriptNov 13, 2019
- Q3 2019 MEDNAX Inc Earnings Call TranscriptNov 01, 2019$16.65 (+0.36%)Earnings
- Q2 2019 MEDNAX Inc Earnings Call TranscriptAug 01, 2019$19.9Earnings
- MEDNAX Inc at Jefferies Healthcare Conference TranscriptJun 04, 2019
- MEDNAX Inc at UBS Global Healthcare Conference TranscriptMay 20, 2019
- MEDNAX Inc at Bank of America Merrill Lynch Health Care Conference TranscriptMay 14, 2019
- Q1 2019 MEDNAX Inc Earnings Call TranscriptMay 02, 2019$20.67 (-1.29%)Earnings
- MEDNAX Inc at Raymond James Institutional Investors Conference TranscriptMar 04, 2019
Pediatrix Medical Group Inc at Bank of America Global Healthcare Conference Transcript
May 10, 2023 / 12:00AM GMT
Release Date Price:
$14.39
(-0.21%)
Kevin Mark Fischbeck
BofA Securities, Research Division - MD in Equity Research
It's my pleasure to be wrapping up day 1 of the conference with the Pediatrix Medical Group, which is the leading provider of pediatric care, a large hospital base across the country. Presenting today, we have Jim Swift, CEO; Curt Pickert, COO; and Charlie Lynch, SVP of Finance and Strategy. Today, we're just going to jump kind of right into Q&A.
James D. Swift
Pediatrix Medical Group, Inc. - CEO & Director
Sure.
Questions & Answers
Kevin Mark Fischbeck;James D. Swift
BofA Securities, Research Division - MD in Equity Research;
So I guess over the last, call it, 5 years or so, there's been a big transformation of the company back to the core roots of the pediatric business. We'd love to just kind of maybe level set for everybody how you guys are thinking about the core growth of the business and what the margin profile of the business should be looking like over the next several years.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)